Articles From: Department of Environmental Protection and American Water Resources Announce That More Than 100,000 Homeowners Have Enrolled in Service Line Protection Program to Derma Sciences Acquires 7.3% of Comvita to Support Vertical Integration of Key Component in MEDIHONEY® Products


New York City Department of Environmental Protection (DEP) Commissioner Carter Strickland and American Water Resources (AWR) President Malcolm Conner today announced that more than 100,000 homeowners in New York City have signed up for the water and sewer Service Line Protection Program that launched in January.
Sign-up for Department of Environmental Protection and American Water Resources Announce That More Than 100,000 Homeowners Have Enrolled in Service Line Protection Program investment picks
RIVERSIDE, Calif., Sept.
Sign-up for Department of Homeland Security and the Department of Interior Now Purchasing Ingen Products investment picks
--Oxyview – Smart Nasal Cannula – Durable, Reliable, More Accurate, Cost Competitive – Respiratory $8 Billion Dollar a Year Business – Ingen Projects $50M Potential Annual Sales in Respiratory Market Sector—Department of Interior and Homeland Security Purchase Orders for IGNT with US Coast Guard and Naval Air Forces--
Sign-up for Department of Homeland Security Purchases Ingen's Medical Products investment picks
Increased Scrutiny Heightens Fiduciary Liability of 401(k) Plan Sponsors ROSELAND, N.J. , Nov.
Sign-up for Department of Labor Expands Audit and Enforcement Focus, Imposing $1.27 Billion in Fines investment picks
2013/9/12
The Office of Workers' Compensation Programs (OWCP) has signed a three-year, $89 million contract renewal with Xerox (NYSE:XRX) to manage medical bills.
Sign-up for Department of Labor Selects Xerox to Administer Disability Compensation Programs investment picks
Tour Includes 24 Dates Across 21 North American Cities Including Sold-Out Shows In New York City, Los Angeles, Toronto and Las Vegas European Summer Stadium Tour Draws Over 1 Million Fans Band To Return To Europe For Arena Tour This Winter LOS ANGELES , Aug.
Sign-up for Depeche Mode Kicks Off North American Leg Of Acclaimed THE DELTA MACHINE WORLD TOUR Tomorrow, August 22 In Detroit investment picks
Depomed to host investor conference call today at 5:00 p.m. EST, 2:00 p.m. PST NEWARK, Calif.
Sign-up for Depomed Acquires CAMBIA® (Diclofenac Potassium for Oral Solution) Migraine Medicine from Nautilus Neurosciences for $48.7 Million investment picks
2014/1/29
NEWARK, Calif.
Sign-up for Depomed Announces Favorable Markman Ruling in GRALISE® Patent Litigation investment picks
Signature Support™ Program offers a full-range of services to simplify coverage support and patient assistance for patients taking Lazanda NEWARK, Calif.
Sign-up for Depomed Announces the Launch of Lazanda® (fentanyl) Nasal Spray and the Signature Support™ Program for Patients with Breakthrough Cancer Pain investment picks
2014/3/12
Conference call scheduled for today at 4:30 PM Eastern Time Dial in information included below NEWARK, Calif.
Sign-up for Depomed Reports Fourth Quarter and Full Year 2013 Financial Result investment picks
2014/2/25
Company to present at upcoming RBC and Cowen investor conferences NEWARK, Calif.
Sign-up for Depomed Reports Preliminary Q4 2013 and Full Year Financial Information investment picks
Total revenues increase to $30 million resulting in a profitable and cash flow positive quarter Conference call scheduled for today at 5:00 PM EDT Dial in information included below NEWARK, Calif.
Sign-up for Depomed Reports Second Quarter 2013 Financial Results investment picks
2013/11/5
Total revenues increase to $37.5 million and EPS of $0.11 per share Conference call scheduled for today at 5:00 PM EST Dial in information included below NEWARK, Calif.
Sign-up for Depomed Reports Third Quarter 2013 Financial Results investment picks
Cash to support future product acquisitions Depomed to host investor conference call today at 5:00 p.m. EDT, 2:00 p.m. PDT NEWARK, Calif.
Sign-up for Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million investment picks
NEWARK, Calif.
Sign-up for Depomed To Present At Piper Jaffray 2013 Healthcare Conference investment picks
NEWARK, Calif.
Sign-up for Depomed To Present At Stifel Nicolaus Healthcare Conference investment picks
2014/3/5
NEWARK, Calif.
Sign-up for Depomed To Present At The 26th Annual ROTH Conference On Monday, March 10, 2014 investment picks
2014/2/20
NEWARK, Calif.
Sign-up for Depomed To Present At Upcoming Healthcare Conferences investment picks
2014/3/10
NEWARK, Calif.
Sign-up for Depomed To Report Fourth Quarter Fiscal Year 2013 Financial Results On Wednesday, March 12, 2014 investment picks
2013/8/1
NEWARK, Calif.
Sign-up for Depomed To Report Second Quarter Fiscal Year 2013 Financial Results On Wednesday, August 7, 2013 investment picks
2013/12/12
NEW YORK , SINGAPORE and SHANGHAI , Dec.
Sign-up for Depth and Breadth of Excellence of Omnicom Agencies On Full Display at Campaign Asia-Pacific Agency of the Year Awards investment picks
TORONTO--A fire caused by the derailment Saturday of a train carrying crude oil and liquefied petroleum gas in Alberta was still burning Monday, and more than 100 people remained evacuated.
Sign-up for Derailed Fuel Cars Still Burning in Alberta investment picks
2014/3/10
SAN DIEGO , March 10, 2014 /PRNewswire/ -- Qualcomm Incorporated (NASDAQ: QCOM) today announced that Derek Aberle , executive vice president of Qualcomm Incorporated and group president has been promoted to president of Qualcomm Incorporated.
Sign-up for Derek Aberle Named Qualcomm President investment picks
Derek Stimson announces filing of Early Warning Report in respect of Rocky Mountain Dealerships Inc. Canada NewsWire Prior to giving effect to the Acquisition, Mr.
Sign-up for Derek Stimson announces filing of Early Warning Report in respect of Rocky Mountain Dealerships Inc. investment picks
CME Group Inc.'s (CME) third-quarter profit rose 8.6% as the exchange operator's trading volume improved on growth in interest-rate contracts.
Sign-up for Derivatives Shift Lifts CME Earnings investment picks
2013/9/4
Derma Sciences, Inc. (Nasdaq:DSCI) , a medical device and pharmaceutical company focused on advanced wound care, today announced a $7.0 million strategic investment in Comvita Limited (NZX:CVT), a global natural health and beauty products company based in New Zealand, with the purchase of approximately 2.3 million newly issued common shares.
Sign-up for Derma Sciences Acquires 7.3% of Comvita to Support Vertical Integration of Key Component in MEDIHONEY® Products investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Department of Environmental Protection and American Water Resources Announce That More Than 100,000 Homeowners Have Enrolled in Service Line Protection Program to Derma Sciences Acquires 7.3% of Comvita to Support Vertical Integration of Key Component in MEDIHONEY® Products
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity